MARC details
| 000 -LEADER |
|---|
| fixed length control field |
03611cam a2200361Ii 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
on1060524449 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
OCoLC |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20181203021420.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
181101s2018 nyuaf e b 001 0 eng d |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
FMG |
| Language of cataloging |
eng |
| Description conventions |
rda |
| Transcribing agency |
FMG |
| Modifying agency |
PCX |
| -- |
QQ3 |
| -- |
OCLCO |
| -- |
IK2 |
| -- |
OQX |
| -- |
GL4 |
| -- |
IMT |
| -- |
VP@ |
| -- |
NHP |
| -- |
HQD |
| -- |
BDX |
| -- |
ORK |
| -- |
CZA |
| -- |
VHP |
| -- |
UAP |
| -- |
IGA |
| -- |
NFG |
| 019 ## - |
|---|
| -- |
1057735066 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781455568505 |
| Qualifying information |
(hardcover) |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
1455568503 |
| Qualifying information |
(hardcover) |
| 035 ## - SYSTEM CONTROL NUMBER |
|---|
| System control number |
(OCoLC)1060524449 |
| Canceled/invalid control number |
(OCoLC)1057735066 |
| 037 ## - SOURCE OF ACQUISITION |
|---|
| Source of stock number/acquisition |
Grand Central Pub, C/O Little Brown & Co Order Dept 53 State st 9th Fl, Boston, MA, USA, 02109 |
| Note |
SAN 200-2205 |
| 092 ## - LOCALLY ASSIGNED DEWEY CALL NUMBER (OCLC) |
|---|
| Classification number |
616.994 |
| Item number |
G734 |
| 049 ## - LOCAL HOLDINGS (OCLC) |
|---|
| Holding library |
NFGA |
| 100 1# - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Graeber, Charles, |
| Relator term |
author. |
| 9 (RLIN) |
228062 |
| 245 14 - TITLE STATEMENT |
|---|
| Title |
The breakthrough : |
| Remainder of title |
immunotherapy and the race to cure cancer / |
| Statement of responsibility, etc |
Charles Graeber. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
First edition. |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE STATEMENTS |
|---|
| Place of production, publication, distribution, manufacture |
New York : |
| Name of producer, publisher, distributor, manufacturer |
Twelve, |
| Date of production, publication, distribution, manufacture |
2018. |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
302 pages, 8 unnumbered pages of plates : |
| Other physical details |
illustrations (chiefly color) ; |
| Dimensions |
24 cm |
| 336 ## - CONTENT TYPE |
|---|
| Content Type Term |
text |
| Content Type Code |
txt |
| Source |
rdacontent |
| 337 ## - MEDIA TYPE |
|---|
| Media Type Term |
unmediated |
| Media Type Code |
n |
| Source |
rdamedia |
| 338 ## - CARRIER TYPE |
|---|
| Carrier Type Term |
volume |
| Carrier Type Code |
nc |
| Source |
rdacarrier |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc |
Includes bibliographical references (page 227-288) and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Patient 101006 JDS -- A simple idea -- Glimmers in the darkness -- Eureka, Texas -- The three E's -- Tempting fate -- The chimera -- After the gold rush -- It's time -- Appendix A: Types of immunotherapies now and upcoming -- Appendix B: The breakthrough, in brief -- Appendix C: A brief anecdotal history of disease, civilization, and the quest for immunity. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
Draws on the experiences of patients, physicians, and researchers to explain the revolutionary development of immunotherapy as a treatment for cancer and how that information is being harnessed to create more effective patient therapies. |
| 520 ## - SUMMARY, ETC. |
|---|
| Summary, etc |
"For decades, scientists have puzzled over one of medicine's most confounding mysteries: Why doesn't our immune system recognize and fight cancer the way it does other diseases, like the common cold? As it turns out, the answer to that question can be traced to a series of tricks that cancer has developed to turn off normal immune responses--tricks that scientists have only recently discovered and learned to defeat. The result is what many are calling cancer's "penicillin moment," a revolutionary discovery in our understanding of cancer and how to beat it. In THE BREAKTHROUGH, Graeber guides readers through the revolutionary scientific research bringing immunotherapy out of the realm of the miraculous and into the forefront of twenty-first-century medical science. As advances in the fields of cancer research and the human immune system continue to fuel a therapeutic arms race among biotech and pharmaceutical research centers around the world, the next step--harnessing the wealth of new information to create modern and more effective patient therapies--is unfolding at an unprecedented pace, rapidly redefining our relationship with this all-too-human disease. Groundbreaking, riveting, and expertly told, THE BREAKTHROUGH is the story of the game-changing scientific discoveries that unleash our natural ability to recognize and defeat cancer, as told through the experiences of the patients, physicians, and cancer immunotherapy researchers who are on the front lines. This is the incredible true story of the race to find a cure, a dispatch from the life-changing world of modern oncological science, and a brave new chapter in medical history"--Dust jacket. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Cancer |
| General subdivision |
Alternative treatment. |
| 9 (RLIN) |
101602 |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name as entry element |
Cancer |
| General subdivision |
Immunotherapy. |
| 9 (RLIN) |
379335 |
| 994 ## - |
|---|
| -- |
C0 |
| -- |
NFG |
